This inventor holds 32 USPTO granted patents. Top assignees: Sumitomo Chemical Company, Limited, Sumitomo Pharmaceuticals Company Limited, Masahiko Yamamoto. Active years: 1976-1998.
Location History:
- Osaka, JA (1976 - 1977)
- Nishinomiya, JA (1977 - 1978)
- Nishinomiya, JP (1980 - 1981)
- Higashiawaji, JP (1984)
- Higashiawaji, Higashiyodogawa-ku, Osaka, JP (1986)
- Takarazuka, JP (1988)
- Osaka, JP (1980 - 1992)
- Sakai, JP (1989 - 1998)
Company Filing History:
23 out of 6,957 
9 out of 174 
1 out of 1 Years Active: 1976-1998
Areas of Expertise:
Title: Keiichi Ono: Pioneering Neurotrophic Peptide and PEG Derivative Innovations
Introduction
Keiichi Ono, a prominent inventor based in Osaka, Japan, has significantly contributed to the fields of neurotrophic peptides and polyethylene glycol (PEG) derivatives. With a total of 32 patents to his name, Ono's innovations hold considerable promise for the treatment of neuro-degenerative disorders and the enhancement of protein modifiers.
Latest Patents
Ono's most recent patents underscore his commitment to advancing medical science. One notable invention is titled "Neurotrophic peptide derivatives," which offers human- or rat-derived neurotrophic peptides and their derivatives, as well as precursor peptides and genes encoding these. This invention demonstrates neurotrophic activity, making it an essential resource for treating neuro-degenerative disorders and dementia. Another groundbreaking patent is "Polyethylene glycol derivatives, process for preparing the same," which details high-purity PEG derivatives useful as protein modifiers for various biologically active compounds, including interferons and hormones. This innovation reduces antigenicity and prolongs plasma half-life, enhancing tissue transfer.
Career Highlights
Keiichi Ono's career has been marked by associations with prestigious companies. He has significantly contributed to the Sumitomo Chemical Company Limited and Sumitomo Pharmaceuticals Company Limited, where he leveraged his expertise to develop innovative solutions in the biomedical field.
Collaborations
Throughout his career, Ono has collaborated with esteemed colleagues, including Junki Katsube and Hajime Kawakami. Their combined efforts have led to substantial advancements in their respective fields, underscoring the importance of teamwork in scientific innovation.
Conclusion
With a robust portfolio of patents and a dedication to research and development, Keiichi Ono exemplifies the spirit of innovation in modern science. His contributions, particularly in neurotrophic peptide derivatives and polyethylene glycol modifications, continue to pave the way for advancements in medical treatments and therapies, making a lasting impact on both the scientific community and society at large.